2023 GI Symposium
The Northern California Society for Clinical Gastroenterology (NCSCG) Board and Meeting Planning Committee are pleased to announce that this year’s meeting will be held in-person as a two-day event at the Hyatt Regency Monterey Hotel in Monterey, CA on May 20-21, 2023.
The symposium will provide a unique opportunity to receive a comprehensive update on gastrointestinal diseases from nationally renowned faculty. You will also have ample opportunity to interact with your colleagues, our expert faculty members, and industry representatives, as well as time to enjoy all that Monterey has to offer.
We have reserved a block of rooms for NCSCG members at Hyatt Regency Monterey Hotel, the location of the 2023 GI symposium.
We hope you are as excited as we are for in-person learning and networking, and to enjoy the beautiful surrounding Monterey and Monterey Bay.
Click on the link above for complete conference and registration information. Please feel free to contact the NCSCG with any questions or comments by sending an email to email@example.com.
The NCSCG GI Symposium Planning Committee
Robert Wong, MD; President
Mikhail Alper, PA-C
Nghiem Ha, MD
Bilal Hameed, MD; Treasurer
Neil Stollman, MD
Allied Healthcare Professional $60
Fellow/Resident - Complimentary
Allied Healthcare Professional $100
Additional Industry Representative $400
Fellow/Resident - Complimentary
To become an NCSCG member or renew your membership click here
This activity has been designed to meet the educational needs of physicians, physician assistants, and nurse practitioners involved in the care of patients with gastrointestinal disorders.
Statement of Need
The goal of this program is to provide important clinical and scientific data on the management of gastrointestinal disorders.
Upon completion of this symposium, participants should be better able to:
Describe new data as it pertains to the implications and options for patients as it pertains to their continued care
Apply updated guidelines for care for chronic liver and GI related diseases
Discuss future directions of therapeutics, diagnostics, and technology in the management of GI and liver diseases
In support of improving patient care, this activity has been planned and implemented by Medical Education Resources (MER) and The Northern California Society for Clinical Gastroenterology. MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Medical Education Resources designates this live activity for a maximum of 7.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Disclosure of Relevant Financial Relationships
Medical Education Resources ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, MER identifies relevant financial relationships with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Reported relevant financial relationships are mitigated by MER to ensure that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing learners with high-quality CE activities that promote improvements or quality in health care and not the business interest of an ineligible company.
This activity is supported by educational grants from AbbVie, Ferring Pharmaceuticals, Inc., Phathom Pharmaceuticals, Salix Pharmaceuticals and Takeda Pharmaceuticals U.S.A., Inc.
This activity is jointly provided by Medical Education Resources and the Northern California Society for Clinical Gastroenterology.